Experience the future of healthcare with Hemostemix Inc. ($HEM), a leader in developing advanced treatments for ischemic diseases. With a market capitalization of $4.35 million or more, $HEM is driving innovation in cell therapy.

Know more: https://finance.yahoo.com/quote/HEM.V?p=HEM.V